高级检索
当前位置: 首页 > 详情页

CBP-mediated Wnt3a/beta-catenin signaling promotes ceryical oncogenesis initiated by Piwil2

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing, China [2]Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China [3] Department of Obstetrics and Gynecology, the First Affiliated Hospital of University of Science and Technology of China, Hefei, China [4]Department of Gynecology and Oncology, Anhui Provincial Cancer Hospital, Hefei, China [5]School of Medicine, Tsinghua University, Beijing, China
出处:
ISSN:

关键词: Cervical cancer Piwil2 Wnt signaling Tumor initiating cell CBP

摘要:
Our previous work demonstrated that Piwil2 reactivated by the human papillomavirus oncoproteins E6 and E7 may reprogram somatic cells into tumor-initiating cells (TICs), which contribute to cervical neoplasia lesions. Maintaining the sternness of TICs is critical for the progression of cervical lesions. Here, we determined that canonical Wnt signaling was aberrantly activated in HaCaT cells transfected with lentivirus expressing Piwil2 and in cervical lesion specimens of low-grade squamous intraepithelial lesion, high-grade squamous intraepithelial lesion, and invasive carcinoma. Blocking the i 6-catenin and CREB binding protein interaction with ICG-001 significantly downregulated the reprogramming factors c-Myc, Nano& Oct4, Sox2, and Klf4, thus leading to cell differentiation and preventing tumorigenicity in Piwil2-overexpressing HaCaT cells. Similarly, Piwil2 also critically regulated the canonical Wnt signaling pathway in cervical cancer. We further demonstrated that ICG-001 increased cisplatin sensitivity and significantly suppressed tumor growth of cervical cancer alone or in combination with cisplatin both in vitro and in vivo. The beta-catenin/ CREB binding proteinmediated transcription activated by Piwil2 is essential for the maintenance of TICs, therefore contributing to the progression of cervical oncogenesis.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing, China
通讯作者:
通讯机构: [1]Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing, China [2]Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)